Results 191 to 200 of about 481,368 (398)
A reprogrammed (RP) phage‐based nanovaccine platform has been developed that allows single‐step assembly with precise control over adjuvanticity, antigen density, and nanoparticle size. By enhancing TLR9 activation and neoantigen display, this platform enables a potent personalized vaccine targeting tumor‐specific neoantigens. When combined with immune
Shengnan Huang+10 more
wiley +1 more source
The clinical applications of intrathecal fluorescein in cerebrospinal fluid leak repair. [PDF]
Aljubran HJ+5 more
europepmc +1 more source
FLUORESCEIN FUNDUS PHOTOGRAPHIC STUDIES ON THE CENTRAL SEROUS RETINOPATHY
H Yoshioka, Takashi Sugita
openalex +2 more sources
Vascular abnormalities in disciform degeneration of the macula lutea demonstrated with fluorescein. [PDF]
L Lemke, A. Jütte
openalex +1 more source
Bacteria‐Responsive Nanostructured Drug Delivery Systems for Targeted Antimicrobial Therapy
Bacteria‐responsive nanocarriers are designed to release antimicrobials only in the presence of infection‐specific cues. This selective activation ensures drug release precisely at the site of infection, avoiding premature or indiscriminate release, and enhancing efficacy.
Guillermo Landa+3 more
wiley +1 more source
Fluorescent Metal-Organic Framework Nanoparticles for Explosive Detection. [PDF]
Yu R+6 more
europepmc +1 more source
Rapid Fluorescein and Protein Assay Method for Fluorescent-Antibody Conjugates [PDF]
A. F. Wells+2 more
openalex +1 more source
Soft Robotic Engines with Non‐Reciprocal Motion by Physical Intelligence
Movement is vital, and it requires breaking symmetry. This study introduces a hydrogel engine that achieves non‐reciprocal motion through kinetic asymmetry in repeated actuation cycles. This approach for breaststroke‐swimming‐like motion is embedded inside the material and establishes a new paradigm of physical intelligence for soft robotics.
Oliver Skarsetz+10 more
wiley +1 more source
Obtusifolin ameliorates dry eye model in rats by reducing inflammation and blocking MAPK/NF-κB pathways. [PDF]
Zhu D, Wu XY, Li LC.
europepmc +1 more source